Jacques Billé

Q: What Schools Are Affiliated With Jacques Billé

Jacques Billé is affiliated with the following schools: University of Lausanne, Rockefeller University

Jacques Billé's AcademicInfluence.com Rankings

Jacques Billé

Philosophy

#8639

World Rank

#12053

Historical Rank

Logic

#5664

World Rank

#7081

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jacques Billé's Degrees

PhD Medical Sciences Université Paris Cité
Doctorate Medicine Université Paris Cité

Why Is Jacques Billé Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacques Billé's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. (2008) (4348)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. (2002) (2368)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (2012) (1017)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. (2008) (809)
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters (1995) (806)
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. (1997) (586)
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗ (2008) (579)
Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Bacterial Strains Routinely Isolated in a Clinical Microbiology Laboratory (2010) (538)
Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents (1998) (465)
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. (2004) (463)
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors (1996) (408)
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. (1999) (397)
Detection of Four Plasmodium Species in Blood from Humans by 18S rRNA Gene Subunit-Based and Species-Specific Real-Time PCR Assays (2004) (368)
TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 (2004) (356)
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. (2008) (355)
Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence (2003) (352)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. (2012) (343)
The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents (1999) (343)
A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans (2006) (336)
Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. (1996) (333)
Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents (2003) (332)
New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity (1989) (320)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). (2012) (280)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. (2012) (267)
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. (2008) (261)
Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans (2000) (258)
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Direct Bacterial Identification from Positive Blood Culture Pellets (2010) (253)
An epidemic of food-borne listeriosis in western Switzerland: description of 57 cases involving adults. (1995) (248)
Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata (2001) (245)
CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS (1989) (236)
Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and Granulocytopenia (1993) (235)
EUCAST DEFINITIVE DOCUMENT E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds (2008) (229)
CRZ1, a target of the calcineurin pathway in Candida albicans (2006) (219)
Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry as an Alternative to 16S rRNA Gene Sequencing for Identification of Difficult-To-Identify Bacterial Strains (2010) (199)
Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals (1997) (198)
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. (1994) (197)
A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. (2000) (195)
Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts (2003) (195)
Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. (1994) (190)
Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study (2003) (187)
β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. (2013) (186)
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. (2012) (182)
Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. (2002) (178)
Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species (2004) (177)
Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. (2003) (176)
A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance (2002) (175)
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines (2009) (169)
Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters (2004) (160)
Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. (2009) (158)
Prospective Randomized Comparison of Imipenem-Cilastatin and Piperacillin-Tazobactam in Nosocomial Pneumonia or Peritonitis (1998) (158)
Evaluation of MRSA-Screen, a Simple Anti-PBP 2a Slide Latex Agglutination Kit, for Rapid Detection of Methicillin Resistance in Staphylococcus aureus (1999) (150)
Community-Acquired Pneumonia: A Prospective Outpatient Study (2001) (146)
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses (2006) (137)
Isolation and characterization of a secreted metalloprotease of Aspergillus fumigatus (1993) (136)
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). (2003) (134)
Diagnosis of invasive candidiasis in the ICU (2011) (133)
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole. (2009) (130)
Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. (2002) (125)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. (2012) (123)
Clinical Implications of Mycobacterium kansasii Species Heterogeneity: Swiss National Survey (2003) (121)
Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans (2000) (120)
Multiplex Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification in Human Plasma of Fluconazole, Itraconazole, Hydroxyitraconazole, Posaconazole, Voriconazole, Voriconazole-N-Oxide, Anidulafungin, and Caspofungin (2010) (117)
Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment (1994) (114)
Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia (2010) (109)
Rapid Detection of Candida albicans in Clinical Samples by DNA Amplification of Common Regions from C. albicans-Secreted Aspartic Proteinase Genes (1998) (106)
Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units (2004) (105)
Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods (2006) (104)
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. (2005) (104)
Treatment options of invasive fungal infections in adults. (2006) (103)
Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Sw (2014) (102)
Mutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis (2004) (101)
Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users (1995) (99)
Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay (2011) (99)
Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. (1998) (97)
Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. (1998) (95)
Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood (1983) (94)
Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination (1990) (94)
Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips (1988) (91)
Clinical evaluation of the lysis-centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system (1984) (89)
Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species (2006) (89)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. (2012) (89)
A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group. (2000) (87)
Molecular Detection and Identification of Zygomycetes Species from Paraffin-Embedded Tissues in a Murine Model of Disseminated Zygomycosis: a Collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) Evaluation (2010) (87)
Usefulness of Procalcitonin Serum Level for the Diagnosis of Bacteremia (2001) (87)
ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia (2012) (86)
EUCAST technical note on fluconazole. (2008) (84)
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. (2010) (82)
Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting (1996) (80)
Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia. (1982) (79)
Typing Listeria monocytogenes isolates from fish products and human listeriosis cases (1997) (78)
WHO International Multicenter Listeria monocytogenes Subtyping Study--rationale and set-up of the study. (1996) (78)
Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. (1989) (75)
Extended-Spectrum β-Lactamases of the CTX-M Type Now in Switzerland (2007) (74)
Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions (1997) (72)
Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. (2003) (72)
Early symptoms and outcome ofListeria monocytogenes rhombencephalitis: 14 adult cases (2004) (71)
European expert opinion on the management of invasive candidiasis in adults. (2011) (71)
Changing Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Small Geographic Area over an Eight-Year Period (2007) (70)
Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR–SSCP typing (2001) (70)
A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs. (2006) (68)
Development of polymerase chain reaction assays for detection of Listeria monocytogenes in clinical cerebrospinal fluid samples (1992) (67)
Parachlamydia acanthamoebae enters and multiplies within pneumocytes and lung fibroblasts. (2006) (66)
Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes (2003) (65)
β-Lactam Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus (1991) (65)
Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections. (2002) (65)
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement. (2019) (61)
Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children (2000) (58)
A new selective medium for isolating Listeria spp. from heavily contaminated material (1988) (56)
Exogenous Sources of Pseudomonas aeruginosa in Intensive Care Unit Patients Implementation of Infection Control Measures and Follow-Up With Molecular Typing (2006) (55)
Sulfa Resistance and Dihydropteroate Synthase Mutants in Recurrent Pneumocystis carinii Pneumonia (2003) (53)
Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. (2011) (53)
Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients (2009) (52)
Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. (1994) (52)
Evaluation of a Novel Medium for Screening Specimens from Hospitalized Patients To Detect Methicillin-Resistant Staphylococcus aureus (2003) (51)
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers (1996) (51)
TAC 1 , Transcriptional Activator of CDR Genes , Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR 1 and CDR 2 † (2004) (50)
Risk for Pneumocystis carinii Transmission among Patients with Pneumonia: a Molecular Epidemiology Study (2003) (48)
Changing face of health-care associated fungal infections (2005) (48)
Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. (2000) (48)
Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10-year period (1998-2007). (2011) (47)
Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. (2010) (46)
Antibiotic prophylaxis of experimental endocarditis after dental extractions. (1988) (46)
Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007. (2008) (46)
Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? (2000) (44)
Listeria and Erysipelothrix (2020) (43)
Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring (1989) (42)
Comparison of Automated Strategies for Surveillance of Nosocomial Bacteremia (2007) (42)
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study. (1989) (42)
Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. (2002) (41)
Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. (2002) (40)
Pneumocystis jiroveci Dihydropteroate Synthase Polymorphisms Confer Resistance to Sulfadoxine and Sulfanilamide in Saccharomyces cerevisiae (2004) (40)
Erratum: The European Committee on antimicrobial susceptibility testing - Subcommittee on antifungal susceptibility testing (EUCAST-AFST)*. EUCAST technical note on fluconazole (Clinical Microbiology and Infection (2008) vol. 14(2) (193-195)) (2009) (39)
Enterococcus cecorum septicemia in a malnourished adult patient (1997) (38)
The inflammatory response and tissue damage (1987) (38)
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. (2007) (37)
Isothermal microcalorimetry: a novel method for real-time determination of antifungal susceptibility of Aspergillus species. (2012) (36)
Outbreak of Salmonella braenderup gastroenteritis due to contaminated meat pies: clinical and molecular epidemiology. (2000) (36)
Carriage of Pneumocystis carinii by immunosuppressed patients and molecular typing of the organisms. (2000) (35)
Typing methods to approach Pneumocystis carinii genetic heterogeneity. (1998) (34)
Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals. (2011) (33)
CSF lactate for accurate diagnosis of community-acquired bacterial meningitis (2015) (32)
Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981) (1982) (32)
Prospective Determination of Plasma Imipenem Concentrations in Critically Ill Children (2006) (31)
Full-Course Oral Levofloxacin for Treatment of Hospitalized Patients with Community-Acquired Pneumonia (2004) (31)
Multiplex real-time PCR for the diagnosis of malaria: correlation with microscopy. (2011) (31)
Sensitive Bioassay for Determination of Fluconazole Concentrations in Plasma Using a Candida albicans Mutant Hypersusceptible to Azoles (2001) (31)
Molecular epidemiology of predominant clones and sporadic strains of methicillin resistant Staphylococcus aureus in Switzerland and comparison with European epidemic clones. (2002) (30)
Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance. (1998) (30)
Studies of the detection of Listeria monocytogenes by culture and PCR in cerebrospinal fluid samples from ruminants with listeric encephalitis. (1995) (29)
New Diagnostic Real-Time PCR for Specific Detection of Mycoplasma hominis DNA (2010) (28)
Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists (2005) (28)
Determination of the Copy Number of the Nuclear rDNA and Beta-tubulin Genes of Pneumocystis carinii f. sp. hominis Using PCR Multicompetitors (2000) (28)
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial. (2002) (27)
False-Negative PCR Result Due to Gene Polymorphism: the Example of Neisseria meningitidis (2010) (26)
Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Fluconazole Global Susceptibility Study Group. (1997) (26)
Natural Variability of In Vitro Adherence to Fibrinogen and Fibronectin Does Not Correlate with In Vivo Infectivity of Staphylococcus aureus (2010) (26)
Usefulness of double locus sequence typing (DLST) for regional and international epidemiological surveillance of methicilin-resistant Staphylococcus aureus. (2010) (25)
First Case of Bacteremia and Multifocal Cellulitis Due to Helicobacter canis in an Immunocompetent Patient (2006) (25)
Complete Genome Sequence of Listeria monocytogenes LL195, a Serotype 4b Strain from the 1983–1987 Listeriosis Epidemic in Switzerland (2013) (25)
DISSEMINATED HISTOPLASMOSIS AND AIDS IN SWITZERLAND (1986) (25)
Quantitative antibiogram as a typing method for the prospective epidemiological surveillance and control of MRSA: comparison with molecular typing. (1996) (24)
Percentage, bacterial etiology and antibiotic susceptibility of acute respiratory infection and pneumonia among children in rural Senegal. (2003) (23)
Cardiac involvement in a patient with clinical and serological evidence of African tick-bite fever (2005) (23)
Ultra-Performance Liquid Chromatography Mass Spectrometry and Sensitive Bioassay Methods for Quantification of Posaconazole Plasma Concentrations after Oral Dosing (2010) (23)
Characterization of Listeria strains isolated from soft and semi-soft cheeses (1998) (23)
Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events (2018) (22)
Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients (1993) (22)
[Epidemic listeriosis. Report of 25 cases in 15 months at the Vaud University Hospital Center]. (1985) (22)
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS). (2018) (22)
SME-2-Producing Serratia marcescens Isolate from Switzerland (2007) (21)
[New methods for the diagnosis of implant-associated infections]. (2010) (20)
Analysis of definitions used in clinical research on invasive fungal infections Consensus proposal for new, standardized definitions (1999) (20)
Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection (2010) (20)
Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients (2001) (19)
New nonculture-based methods for the diagnosis of invasive candidiasis (2010) (19)
Gastric and duodenal bacterial colonization in HIV-infected patients without gastrointestinal symptoms. (1994) (18)
Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients (1993) (18)
Right-sided pacemaker-related endocarditis due to Acremonium species. (1997) (18)
Molecular typing methods and their discriminatory power. (1998) (17)
Polymorphisms in Tumor Necrosis Factor-&agr; Increase Susceptibility to Intra-Abdominal Candida Infection in High-Risk Surgical ICU Patients* (2014) (17)
Histoplasma capsulatum var. duboisii infection in a patient with AIDS: rapid diagnosis using polymerase chain reaction-sequencing. (2009) (17)
Effect of indomethacin on the incidence of experimental Escherichia coli pyelonephritis (1983) (15)
Quantitative Antibiogram as a Typing Method for the Prospective Epidemiological Surveillance and Control of MRSA Comparison with Molecular Typing (1996) (15)
Fungal Eosinophilic Peritonitis Due to AL Ternaria in a Patient on Continuous Ambulatory Peritoneal Dialysis (1984) (13)
Evaluation of the Organon-Teknika MICRO-ID LISTERIA system (1992) (13)
1,3- b - d -Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia (2008) (12)
Cobas-Bact system for identification of members of the family Enterobacteriaceae in 4 h 20 min (1987) (12)
Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue (2003) (12)
Genome Sequences of Listeria monocytogenes Strains Responsible for Cheese- and Cooked Ham Product-Associated Swiss Listeriosis Outbreaks in 2005 and 2011 (2016) (12)
Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent. (2017) (11)
When shouldCandida isolates be tested for susceptibility to azole antifungal agents? (1997) (11)
MAPT (mono antiplatelet therapy) as regular regimen after COBRA PzF™ NanoCoated Coronary stent (NCS) implantation. (2019) (11)
Medical treatment of staphylococcal infective endocarditis. (1995) (11)
Laboratory diagnosis of infections in febrile neutropenic or immunocompromised patients. (2000) (11)
Candida arteritis in patients who have not received organ transplants: case report and review of the literature. (2008) (11)
Asymptomatic oral yeast carriage in HIV-infected patients: frequency and fluconazole susceptibility profile. (1996) (11)
[Diagnosis of invasive fungal infections]. (2005) (11)
Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of gram-negative rods from positive blood culture broths (1989) (10)
Transmission of oral Candida albicans strains between HIV-positive patients (1995) (9)
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study. (2018) (9)
In vitro sensitivity of 65 Listeria monocytogenes isolates to new and old antibiotics. (1987) (9)
The detection of mycobacteria in blood cultures using the Bactec system: 6 weeks versus 12 weeks of incubation? routine terminal Ziel-Neelsen? (1998) (8)
Quantitative Analysis of Cellular Fatty Acids (CFAs) Composition of the Seven Species of Listeria (1992) (8)
Single-dose rifampin prophylaxis for experimental endocarditis induced by high bacterial inocula of viridans streptococci. (1987) (8)
Unusual clinical features of an epidemic of listeriosis associated with a particular phage type (1986) (8)
Development of a Molecular Typing Method for Pneumocystis carinii sp.f. hominis (1996) (8)
Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue (2004) (8)
Seroprevalence of rubella among women of childbearing age in Switzerland (1995) (7)
Evaluation of the susceptibility of pathogenicCandida species to fluconazole (1997) (7)
Pneumocystis jirovecii Dihydrofolate Reductase Polymorphisms Associated with Failure of Prophylaxis (2003) (7)
Typing of Pneumocystis carinii sp.f. hominis by PCR‐SSCP of Four Genomic Regions (1997) (7)
Value of the comparative enzyme-linked immunofiltration assay for early neonatal diagnosis of congenital Toxoplasma infection. (1999) (7)
[Disseminated histoplasmosis due to Histoplasma capsulatum in a patient with acquired immunodeficiency syndrome (AIDS)]. (1987) (6)
In-vitro activity of temafloxacin for gram-positive pathogens. (1991) (6)
ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases. (2012) (6)
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infection in Burkina Faso. (2009) (6)
Geographical Variation in the Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Mutations Within Western Europe (2006) (6)
Potential Coinfections Complicate Typing of Pneumocystis carinii f. sp. hominis (1998) (6)
Ampicillin-Sensitive, Imipenem-Resistant Strains of Enterococcus faecium (2002) (6)
In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland. (1997) (5)
MALDI-TOF mass spectrometry for direct bacterial identification 1 from positive blood culture pellets (2010) (5)
Clinical features and analysis of the duration of colonisation during an outbreak of Salmonella braenderup gastroenteritis. (2000) (5)
Comparison of the value of DNA-fingerprinting techniques for the identification and taxonomical classification of Listeria species (1998) (5)
[Systemic mycotic infections: epidemiology and diagnostic criteria]. (1995) (5)
Disseminated histoplasmosis in Switzerland: an unexpected cause of septic shock and multiple organ dysfunction (2002) (5)
[Brucellosis: a varied clinical presentation in 9 patients]. (1984) (5)
Correlation between in vitro and in vivo activity of antifungal agents against yeasts (1996) (5)
1 , 3-bd-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia (2008) (5)
Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia (2017) (5)
Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virus (1989) (5)
Retrospective comparison of three blood culture media for the recovery of yeasts from clinical specimens (1983) (4)
Verocytotoxin-Producing Escherichia coli in Patients with Diarrhoea in Switzerland (2002) (4)
Prevention of acute and chronic ascending pyelonephritis in rats by aminoglycoside antibiotics accumulated and persistent in kidneys (1981) (4)
Mechanisms and clinical significance of antifungal resistance. (2000) (4)
[Disseminated nocardiosis due to Nocardia brasiliensis in an ambulatory patient]. (1989) (4)
Molecular methods for rapid microbiologic diagnosis (1998) (3)
Development of a molecular typing method for Pneumocystis carinii sp.f. hominis (1997) (3)
178 – Aerobic Gram-Positive Bacilli (2017) (3)
[Antibiotic sensitivity of bacteria isolated in the laboratory of a small hospital compared to those of a large hospital]. (1991) (3)
Cerebral vasculitis complicating postoperative meningitis: the role of steroids revisited. (2012) (3)
Site‐Directed Mutagenesis of the Saccharomyces cerevisiae Dihydropteroate Synthase FOL1 Gene to Study Pneumocystis jirovecii Mutations in the Orthologue Gene FAS (2003) (3)
Rapid coagglutination test for the direct detection of group A streptococci from throat swabs (1986) (3)
Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus. (1991) (3)
Candida Species Distribution and Antifungal Susceptibility Testing According to EUCAST and New vs. Old CLSI Clinical Breakpoints: a Six-Year Prospective Candidemia Survey from the Fungal Infection Network of Switzerland (FUNGINOS) (2017) (3)
Etiology of community-acquired pneumonia. (1986) (3)
Prophylaxis of pyelonephritis by aminoglycosides accumulated in the kidney. (1981) (3)
In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients (2006) (3)
[Use of POCT (point of care tests) in the diagnosis of infectious diseases]. (2008) (2)
[Multicenter evaluation of oral antibiotics: resistance behavior in 5 Swiss centers]. (1994) (2)
Assessment of normal and abnormal prosthetic mitral valves by Doppler echocardiography (1990) (2)
Les infections de la main (1999) (2)
Evaluation of a rapid latex agglutination test (Directigen®) for the direct detection of group A streptococci from throat swabs (1985) (2)
[Candida fungemia]. (1989) (2)
[Comparative study of the treatment of simple urinary infection with a single dose of norfloxacin versus cotrimoxazole]. (1987) (2)
[Invasive Haemophilus infections in adults]. (1986) (2)
[Coronary angioplasty in patients aged 70 and over. Immediate results and later outcome]. (1990) (1)
[Community-acquired pneumonias: importance of pneumococcal pathology]. (1985) (1)
Chapter 167 – Aerobic Gram-positive bacilli (2010) (1)
Clinical Performance of FXGTM: RESP (Asp +) assay for Aspergillus on respiratory specimens (2008) (1)
OUTCOMES AFTER TRANSTHORACIC, PERIPHERAL VASCULAR AND TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION: A PROPENSITY ANALYSIS FROM FRANCE TAVI REGISTRY (2018) (1)
P1297 Double locus sequence typing, a new fast and unambiguous typing method to study the epidemiology of MRSA at a regional level (2007) (1)
[Clinical spectrum of a common and insidious pathogen: Streptococcus milleri]. (1988) (1)
Evaluation of the Cobas-Bact system for direct and rapid identification and antimicrobial susceptibility testing of Enterobacteriaceae from positive urine specimens. (1989) (1)
Clinical Performance of FXGTM : RESP (Asp +) assay for Pneumocystis jirovecii on respiratory specimens (2008) (1)
Microbiological diagnosis of community-acquired respiratory tract infections by nucleic acid detection. (2008) (1)
Histoplasmose disseminee a Histoplasma capsulatum chez un patient presentant un syndrome d'immunodeficience acquise (SIDA). [Disseminated histoplasmosis due to Histoplasma capsulatum in a patient with acquired immunodeficiency syndrome (AIDS)] (1987) (1)
Evaluation of the Cobasbact system for rapid antimicrobial susceptibility testing of positive blood culture broths (1985) (1)
Resistance in Staphylococcus aureus for Rapid Detection of Methicillin Anti-PBP 2a Slide Latex Agglutination Kit, Evaluation of MRSA-Screen, a Simple (2013) (1)
Susceptibility of Fungal or Yeast Bloodstream Isolates to Antifungals: Results from a National Study (2001) (1)
[Pneumococcal bacteremia: what is new?]. (1995) (1)
[In-vitro activity of cefuroxime-axetil against pathogens of bacterial infections of the respiratory tract]. (1990) (1)
Monitoring of 1,3-Beta-D-Glucan (BGL) Antigenemia in Neutropenic Patients with Acute Leukemia at High Risk for Invasive Fungal Infections (IFI). (2006) (1)
[Percutaneous extraction of a silicone catheter 5 years after its migration in the pulmonary artery]. (1995) (1)
Antimicrobial Activity and Spectrum of Daptomycin Tested Against Gram-positive Strains Collected in European Hospitals: Results from 7 Years of Surveillance (2003-2009) (2011) (1)
Clinical microbiology--the model of the University Hospital of Lausanne, Switzerland. (2000) (1)
Online‐Only Abstracts (2011) (0)
Evaluation of the 5-h Cobas-Bact® identification rotor for Enterobacteriaceae. A preliminary report (2005) (0)
Interpretation and Update of Molecular Amplification Tests for Routine Clinical Practice (2006) (0)
Le diagnostic moléculaire des infections en 1999 (1999) (0)
Les drop attacks (1995) (0)
albicans Candida Experimental Endocarditis Due to Fungicidal Combination Effective against Fluconazole plus Cyclosporine : a (2000) (0)
CSF lactate for accurate diagnosis of community-acquired bacterial meningitis (2015) (0)
[Diagnostic and treatment of community-acquired pneumonia in the adult. Recommendations for clinical practice. By the "Practice guidelines for community-acquired pneumonia" Work Group]. (1999) (0)
NewDiagnostic Real-Time PCR for Specific Detection of Mycoplasmahominis DNA (2010) (0)
and DNA fingerprinting. patients by multilocus enzyme electrophoresis human immunodeficiency virus-infected Typing Candida albicans oral isolates from (2013) (0)
A New Selective MediumforIsolating Listeria spp. fromHeavily Contaminated Material (1988) (0)
[Diagnosis of materno-fetal toxoplasmosis]. (2000) (0)
La malédiction du favori (2017) (0)
The characterization of Swedish human Listeria monocygtogenes strains isolated 1958–1994 (1995) (0)
140 Multi resistant Pseudomonas aeruginosa outbreak caused by multiple sources and strains (2006) (0)
Caspofungin for Prophylaxis of Intraabdominal Candidiasis in High-Risk Surgical Patients: a Pilot Study (2008) (0)
Clinical Evaluation oftheLysis-Centrifuga tion BloodCulture SystemfortheDetection ofFungemia andComparison with a Conventional Biphasic BrothBloodCulture System (1984) (0)
Division of Listeria monocytogenesSerovar 1/2a Strains into Two Groups by PCR and Restriction Enzyme Analysis (1999) (0)
application in various enrichment broths. kit for rapid colony confirmation and its monocytogenes culture identification reagent Assessment of the Accuprobe Listeria (2013) (0)
[Early reocclusion after in situ coronary desobstruction either with streptokinase or angioplasty during the acute phase of myocardial infarction]. (1990) (0)
Pilot Study on Septifast PCR for the Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia (2008) (0)
biphasic broth blood culture system. fungemia and comparison with a conventional blood culture system for the detection of Clinical evaluation of the lysis-centrifugation (2013) (0)
Detection of Community-acquired Respiratory Tract Pathogens by Molecular Amplification (2006) (0)
[Pneumonia: etiologic diagnosis and therapy in general practice]. (1992) (0)
Cross-Infection with Candida in the Intensive Care Unit (2002) (0)
P1305 Double locus sequence typing a new high through put typing method for MRSA. Results from a 1.5-year surveillance in a university hospital (2007) (0)
Molecular epidemiology and surveillance of listeriosis (1998) (0)
[Doctor, I have a lymph node]. (2009) (0)
Reply to Pasqualotto and Sukiennik. (2008) (0)
Direct 5-h Cobas-Bact® susceptibility testing of gram stain confirmed positive urine samples (2005) (0)
Prospective Randomized Comparison of Imipenem Monotherapy with Imipenem plus Netilmicin for Treatment of Severe Infections in Nonneutropenic Patientst (0)
[Pneumonia: identification of respiratory pathogens]. (1991) (0)
111 Combined galactomannan (GMn), Mannan (Mn), and anti-mannan (AMn) for diagnosis of invasive fungal infections (IFI) in neutropenic cancer patients (Pts) (2006) (0)
155 Chlamydia-like organisms: A role as new agents of pneumonia? (2006) (0)
Disseminated disease caused by Nocardia brasiliensis in an immunodepressed patient. (1990) (0)
Prospective Randomized Comparison of Imipenem-Cilastatin and Piperacillin-Tazobactam in Nosocomial Pneumonia or Peritonitis (1999) (0)
Swedish human cases of Listeriosis, 1958–1999 : Visulized by LEGO Bricks (2000) (0)
Extended-Spectrum (cid:2) -Lactamases of the CTX-M Type Now in Switzerland (cid:1) (2007) (0)
[Nucleic probes and PCR: application in the diagnosis of bacterial infections]. (1994) (0)
Staphylococcus aureus in a Small Geographic Area over a 8 (2007) (0)
Septifast PCR for the Microbiological Documentation of Infections in Febrile Neutropenic Patients (2008) (0)
{3-lactam Antibiotics Active against Methicillin- Resistant Staphylococcus aureus (2010) (0)
Ultra-Performance Liquid Chromatography Mass Spectrometry and Sensitive Bioassay Methods for Quantiﬁcation of Posaconazole Plasma Concentrations after Oral Dosing (cid:1) (2010) (0)
[Hand infections]. (1999) (0)
0133: The first human experience with novel nano surface modified Cobra PzF stent (2015) (0)
[Protection against ascending pyelonephritis by means of preventive aminoglucoside administration]. (1980) (0)
Microbiology of the Lower Digestive Tract (2010) (0)
Evaluation oftheOrganon-Teknika MICRO-ID LISTERIASystem (2015) (0)
Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia (2018) (0)
Site-Directed Mutagenesis of the Saccharomyces cerevisiaeDihydropteroate Synthase FOL1 Gene to Study Pneumocystis jiroveciiMutations in the Orthologue Gene FAS (2003) (0)
[3-Lactam Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus (2010) (0)
Three important clones of Listeria monocytogenes (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jacques Billé?

Jacques Billé is affiliated with the following schools: